Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Active ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

NewsVoir Mumbai (Maharashtra) [India], October 12: Flawless Pharma Pvt. Ltd. has engaged with a major European contract development and manufacturing organization (CDMO) & a leading African firm in ...

Recipharm is pleased to announce that it has signed an agreement with Daewoong, the leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year ...

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective on the API market and why it is important to qualify API suppliers. APIs ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...

The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...